CDRO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
CDRO is not a clear buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The technical setup is mildly constructive, but the stock is still trading near analyst targets, there is no strong proprietary buy signal, and there has been no recent news or financial catalyst to justify an aggressive long-term purchase today. For an impatient investor, this is better treated as a hold than an immediate buy.
The technical picture is mixed to slightly positive. Price closed at 9.65, just above the 9.386 pivot, with bullish moving averages in place (SMA_5 > SMA_20 > SMA_200). MACD histogram is positive at 0.00228, though it is contracting, which suggests upside momentum is present but fading. RSI_6 at 56.393 is neutral-to-mildly bullish, not overbought. Near-term resistance sits at 10.054 and 10.467, while support is at 8.717 and 8.304. Overall, the trend is constructive but not strong enough to call it a high-conviction entry.
["Parent company Codere Group has reportedly started a formal sale process, which could create a takeout or strategic simplification catalyst for the online unit.", "Bullish moving average alignment suggests the broader trend remains upward.", "MACD remains above zero, indicating momentum is still positive.", "The stock is trading near recent analyst price targets, which can support sentiment."]
["No news in the recent week, so there is no fresh event-driven catalyst.", "AI Stock Picker shows no signal today and SwingMax shows no recent signal.", "Analysts remain at Hold despite raising targets, which limits conviction.", "Hedge funds and insiders are neutral with no meaningful accumulation trend.", "The stock is already close to the latest $10 target, leaving limited upside from current levels."]
No usable latest-quarter financial snapshot was provided because the financial data returned an error. As a result, there is no reliable quarter-over-quarter revenue or earnings growth assessment available from the supplied data.
Stifel raised the price target twice, from $8.50 to $9 on 2026-03-26 and then to $10 on 2026-05-08, but kept a Hold rating both times. That means Wall Street sees some improving value or takeover optionality, but not enough fundamental strength to rate it a Buy. Pros: rising target, possible parent sale catalyst, and corporate simplification could benefit the stock. Cons: the official stance is still Hold, so the pros do not yet outweigh the lack of stronger conviction.
